AT

Alan Taylor

Clarity Pharmaceuticals Ltd | Executive Chairman, Executive Director
Dr Taylor has 15 years of investment banking experience focused predominantly on the life sciences sector, and has expertise in capital raisings, mergers and acquisitions, and general corporate advisory. Prior to joining Clarity, he was an Executive Director of Inteq Limited, a boutique Australian investment bank.

Company and Roles

Company
Title
Tenure
Since
CU6
CU6
Clarity Pharmaceuticals Ltd
  • Executive Chairman
  • Executive Director
12yrs, 7mthNov 2013

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CU6
CU6
Clarity Pharmaceuticals Ltd
25/11/252,219,15114,066,6604,851,793N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CU6
CU6
Clarity Pharmaceuticals Ltd
25/11/25
Issued
1,262,838$1.616$2,041,200Issue of options
CU6
CU6
Clarity Pharmaceuticals Ltd
01/07/25
Exercise
1,000,000$0.938$937,500Exercise of options
CU6
CU6
Clarity Pharmaceuticals Ltd
01/07/25
Buy
592,373$1.583$937,500Exercise of options
CU6
CU6
Clarity Pharmaceuticals Ltd
20/11/24
Issued
740,748$2.756$2,041,200Issue of options
CU6
CU6
Clarity Pharmaceuticals Ltd
01/10/24
Buy
1,083,776$0.913$990,000Exercise of options